January 4, 2024 12:56 PM | 1 min read
- Sellas Life Sciences stocks have plummeted by 35.7% on Thursday.
- The company’s announcement of a $9 million public offering has led to the decline.
Sellas Life Sciences Group Inc SLS shares are trading lower by 35.7% to $0.58 Thursday
afternoon. The stock is trading lower after the company announced pricing of a $9 million public offering.
Untangling the Web
The issuance of 12 million shares of common stock alongside accompanying warrants
aims to raise $9 million before expenses.
Priced at $0.75 per share and warrant, these securities will grant the option to
purchase an equal number of shares at the same price within five years.
A.G.P./Alliance Global Partners acts as the exclusive placement
agent for this offering, set to conclude around January 8, pending standard closing conditions.
Also Valuable: December Jobs Report Preview
Data from Benzinga Pro reveals that SLS has reached a 52-week high of $4.13 and a
low of $0.58.
